Published in Biochem J on May 01, 1997
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science (1986) 15.84
Induction of c-fos gene and protein by growth factors precedes activation of c-myc. Nature (1985) 9.73
Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell (1994) 8.65
c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science (1994) 5.97
Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini. Cell (1983) 5.79
Induction of proto-oncogene JUN/AP-1 by serum and TPA. Nature (1988) 5.18
Avian sarcoma virus 17 carries the jun oncogene. Proc Natl Acad Sci U S A (1987) 4.96
Bone and haematopoietic defects in mice lacking c-fos. Nature (1993) 4.07
Calcium-activated neutral protease (calpain) system: structure, function, and regulation. Physiol Rev (1991) 3.53
c-jun is essential for normal mouse development and hepatogenesis. Nature (1993) 3.43
A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture. Genes Dev (1993) 3.21
The jun and fos protein families are both required for cell cycle progression in fibroblasts. Mol Cell Biol (1991) 3.08
Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell (1992) 2.78
Efficient transformation of chicken embryo fibroblasts by c-Jun requires structural modification in coding and noncoding sequences. Genes Dev (1990) 2.46
PEST sequences are signals for rapid intracellular proteolysis. Semin Cell Biol (1990) 1.89
Nuclear localization of c-Fos, but not v-Fos proteins, is controlled by extracellular signals. Cell (1990) 1.59
FBR murine osteosarcoma virus. I. Molecular analysis and characterization of a 75,000-Da gag-fos fusion product. Virology (1984) 1.55
FBR murine osteosarcoma virus. II. Nucleotide sequence of the provirus reveals that the genome contains sequences acquired from two cellular genes. Virology (1984) 1.53
Degradation of the proto-oncogene product c-Fos by the ubiquitin proteolytic system in vivo and in vitro: identification and characterization of the conjugating enzymes. Mol Cell Biol (1995) 1.48
Structure-function analysis of fos protein: a single amino acid change activates the immortalizing potential of v-fos. Cell (1987) 1.47
The avian cellular homolog of the oncogene jun. Oncogene (1988) 1.42
Ubiquitinylation is not an absolute requirement for degradation of c-Jun protein by the 26 S proteasome. J Biol Chem (1995) 1.37
c-fos proto-oncogene regulation and function. Crit Rev Oncol Hematol (1994) 1.25
Specific cleavage of transcription factors by the thiol protease, m-calpain. Nucleic Acids Res (1993) 1.15
Degradation of transcription factors, c-Jun and c-Fos, by calpain. FEBS Lett (1991) 1.13
Inhibition of calpain by a synthetic oligopeptide corresponding to an exon of the human calpastatin gene. J Biol Chem (1989) 1.13
Differential sensitivity of FOS and JUN family members to calpains. Oncogene (1994) 1.00
Selective uptake and degradation of c-Fos and v-Fos by rat liver lysosomes. FEBS Lett (1996) 0.99
PEST motifs are not required for rapid calpain-mediated proteolysis of c-fos protein. Biochem J (1996) 0.91
fau cDNA encodes a ubiquitin-like-S30 fusion protein and is expressed as an antisense sequence in the Finkel-Biskis-Reilly murine sarcoma virus. Oncogene (1993) 0.85
Ubiquitinylation of transcription factors c-Jun and c-Fos using reconstituted ubiquitinylating enzymes. J Biol Chem (1996) 0.83
Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res (1985) 10.76
Extreme instability of myc mRNA in normal and transformed human cells. Proc Natl Acad Sci U S A (1984) 5.09
Post-transcriptional regulation of glyceraldehyde-3-phosphate-dehydrogenase gene expression in rat tissues. Nucleic Acids Res (1984) 4.79
c-myc gene is transcribed at high rate in G0-arrested fibroblasts and is post-transcriptionally regulated in response to growth factors. Nature (1985) 3.01
Regulation of c-fos gene expression in hamster fibroblasts: initiation and elongation of transcription and mRNA degradation. Nucleic Acids Res (1987) 2.87
Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood (1989) 2.78
Posttranscriptional mechanisms are responsible for accumulation of truncated c-myc RNAs in murine plasma cell tumors. Cell (1985) 2.73
Increased rate of degradation of c-myc mRNA in interferon-treated Daudi cells. Proc Natl Acad Sci U S A (1985) 2.35
Unusual abundance of vertebrate 3-phosphate dehydrogenase pseudogenes. Nature (1985) 2.23
Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras. Cell (1994) 2.00
Standardization of mRNA titration using a polymerase chain reaction method involving co-amplification with a multispecific internal control. J Biol Chem (1992) 1.92
Complete nucleotide sequence of the messenger RNA coding for chicken muscle glyceraldehyde-3-phosphate dehydrogenase. Biochem Biophys Res Commun (1984) 1.91
Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer half-lives. EMBO J (1985) 1.76
A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine leukemia virus-derived viruses. Proc Natl Acad Sci U S A (1989) 1.64
Transcriptional and post-transcriptional regulation of c-myc expression during the differentiation of murine erythroleukemia Friend cells. Nucleic Acids Res (1986) 1.62
Nuclear localization of c-Fos, but not v-Fos proteins, is controlled by extracellular signals. Cell (1990) 1.59
Ubiquitinylation is not an absolute requirement for degradation of c-Jun protein by the 26 S proteasome. J Biol Chem (1995) 1.37
Sequence requirements for premature transcription arrest within the first intron of the mouse c-fos gene. Mol Cell Biol (1991) 1.36
Characterization of the transcription products of glyceraldehyde 3-phosphate-dehydrogenase gene in HeLa cells. Eur J Biochem (1984) 1.35
Proteolysis by calpains: a possible contribution to degradation of p53. Mol Cell Biol (1997) 1.30
Chromatin structure of the murine c-myc locus: implications for the regulation of normal and chromosomally translocated genes. EMBO J (1985) 1.30
Targeting of c-myc and beta-globin coding sequences to cytoskeletal-bound polysomes by c-myc 3' untranslated region. Biochem J (1994) 1.18
The 'GGCC' haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera. Leukemia (2009) 1.15
The efficiency of cell targeting by recombinant retroviruses depends on the nature of the receptor and the composition of the artificial cell-virus linker. J Gen Virol (1992) 1.14
Sequence determinants of c-myc mRNA turn-over: influence of 3' and 5' non-coding regions. Oncogene Res (1988) 1.13
Measurement of sigma chi c2 B(chi c2-->J/psi gamma)/sigma chi c1 B(chi c1 -->J/psi gamma) in pp collisions at square root s=1.96 TeV. Phys Rev Lett (2007) 1.07
AUUUA motifs are dispensable for rapid degradation of the mouse c-myc RNA. Oncogene (1990) 1.07
Insertion sequences and tandem repetitions as sources of variation in a dispersed repeat family. J Mol Biol (1983) 1.06
Fra-1 controls motility of bladder cancer cells via transcriptional upregulation of the receptor tyrosine kinase AXL. Oncogene (2011) 1.05
Molecular characterization of the thermosensitive E1 ubiquitin-activating enzyme cell mutant A31N-ts20. Requirements upon different levels of E1 for the ubiquitination/degradation of the various protein substrates in vivo. Eur J Biochem (2000) 1.02
Differential sensitivity of FOS and JUN family members to calpains. Oncogene (1994) 1.00
Plasma proteasome level is a potential marker in patients with solid tumors and hemopoietic malignancies. Cancer (2001) 0.99
Autoimmunity to human thyroglobulin. Respective epitopic specificity patterns of anti-human thyroglobulin autoantibodies in patients with Sjögren's syndrome and patients with Hashimoto's thyroiditis. Arthritis Rheum (1991) 0.97
Heat shock protein 27 is involved in SUMO-2/3 modification of heat shock factor 1 and thereby modulates the transcription factor activity. Oncogene (2009) 0.97
Polarizations of J/psi and psi(2S) mesons produced in pp collisions at square root s = 1.96 TeV. Phys Rev Lett (2007) 0.96
GSK3-SCF(FBXW7) targets JunB for degradation in G2 to preserve chromatid cohesion before anaphase. Oncogene (2012) 0.96
In vivo interleukin 6 gene expression in the tumoral environment in multiple myeloma. Eur J Immunol (1991) 0.95
Systematic exploration of the antigen binding activity of synthetic peptides isolated from the variable regions of immunoglobulins. J Biol Chem (1997) 0.95
Measurement of the top-quark mass in all-hadronic decays in pp collisions at CDF II. Phys Rev Lett (2007) 0.95
Altered c-myc RNA metabolism in Burkitt's lymphomas and mouse plasmacytomas. Curr Top Microbiol Immunol (1986) 0.95
The PKCθ pathway participates in the aberrant accumulation of Fra-1 protein in invasive ER-negative breast cancer cells. Oncogene (2012) 0.94
Identification of a C-terminal tripeptide motif involved in the control of rapid proteasomal degradation of c-Fos proto-oncoprotein during the G(0)-to-S phase transition. Oncogene (2001) 0.93
Concerted evolution in the GAPDH family of retrotransposed pseudogenes. Mamm Genome (1993) 0.92
Production and characterization of monoclonal antibodies against human thyroglobulin. Hybridoma (1985) 0.91
A warning on the use of synthetic DNA primers for initiation of reverse transcription on RNA templates: unexpected initiation at a mismatched nucleotide. Gene (1982) 0.91
PEST motifs are not required for rapid calpain-mediated proteolysis of c-fos protein. Biochem J (1996) 0.91
Antigenic domains on the human thyroglobulin molecule recognized by autoantibodies in patients' sera and by natural autoantibodies isolated from the sera of healthy subjects. Clin Immunol Immunopathol (1987) 0.90
Plasma proteasome level is a reliable early marker of malignant transformation of liver cirrhosis. Gut (2009) 0.90
Mouse DNA sequences complementary to small nuclear RNA U1. Nucleic Acids Res (1982) 0.89
Differential directing of c-Fos and c-Jun proteins to the proteasome in serum-stimulated mouse embryo fibroblasts. Oncogene (1998) 0.89
A major human thyroglobulin epitope defined with monoclonal antibodies is mainly recognized by human autoantibodies. Eur J Immunol (1992) 0.89
An easy method for the selection of restriction- and modification-deficient mutants of Escherichia coli K-12. Gene (1980) 0.89
Cell targeting by murine retroviral vectors. Crit Rev Oncol Hematol (1998) 0.89
Efficient cell infection by Moloney murine leukemia virus-derived particles requires minimal amounts of envelope glycoprotein. J Virol (2000) 0.88
High plasma proteasome levels are detected in patients with metastatic malignant melanoma. Br J Dermatol (2005) 0.88
Significance of the recognition of certain antigenic regions on the human thyroglobulin molecule by natural autoantibodies from healthy subjects. J Immunol (1989) 0.88
[Limit-dose evaluation of serum thymic factor activity]. C R Seances Acad Sci III (1982) 0.88
Comparative study of the L1 family in the genus Mus. Possible role of retroposition and conversion events in its concerted evolution. J Mol Biol (1985) 0.88
Human cyclin C protein is stabilized by its associated kinase cdk8, independently of its catalytic activity. Oncogene (2001) 0.88
Improvement of porphyrin cellular delivery and activity by conjugation to a carrier peptide. Bioconjug Chem (2001) 0.87
Immunotherapy of a viral disease by in vivo production of therapeutic monoclonal antibodies. Hum Gene Ther (2000) 0.87
Complex mechanisms for c-fos and c-jun degradation. Mol Biol Rep (1997) 0.87
Antigen-capture ELISA for viral haemorrhagic septicaemia virus serotype I. J Virol Methods (1990) 0.87
Search for anomalous production of multilepton events in pp collisions at sqrt s=1.96 TeV. Phys Rev Lett (2007) 0.86
The sensitivity of c-Jun and c-Fos proteins to calpains depends on conformational determinants of the monomers and not on formation of dimers. Biochem J (2000) 0.85
MoMuLV-derived self-inactivating retroviral vectors possessing multiple cloning sites and expressing the resistance to either G418 or hygromycin B. Biochimie (1990) 0.85
Altered myc gene transcription and intron-induced stabilization of myc RNAs in two mouse plasmacytomas. Oncogene (1989) 0.85
In vitro and in vivo secretion of cloned antibodies by genetically modified myogenic cells. Hum Gene Ther (1997) 0.84
Long-term expression of the c-fos protein during the in vitro differentiation of cerebellar granule cells induced by potassium or NMDA. Brain Res Mol Brain Res (1992) 0.84
Development of cellulose sulfate-based polyelectrolyte complex microcapsules for medical applications. Ann N Y Acad Sci (1999) 0.84
[The proteasome and malignant hemopathies]. Morphologie (2000) 0.83
The regulatory strategies of c-myc and c-fos proto-oncogenes share some common mechanisms. Biochimie (1988) 0.83
Are there multiple proteolytic pathways contributing to c-Fos, c-Jun and p53 protein degradation in vivo? Mol Biol Rep (1999) 0.83
Tyrosine iodination and iodotyrosyl coupling of the N-terminal thyroid hormone forming site of human thyroglobulin modulate its binding to auto- and monoclonal antibodies. Mol Cell Endocrinol (1992) 0.83
Analysis of the quantum numbers J(PC) of the X(3872) particle. Phys Rev Lett (2007) 0.83
c-fos mRNA instability determinants present within both the coding and the 3' non coding region link the degradation of this mRNA to its translation. Oncogene (1995) 0.83
Heterodimerization with Fra-1 cooperates with the ERK pathway to stabilize c-Jun in response to the RAS oncoprotein. Oncogene (2010) 0.82
Production and partial characterization of anti-Candida monoclonal antibodies. Ann Inst Pasteur Immunol (1986) 0.82
Retrovirus-mediated gene transfer of a human c-fos cDNA into mouse bone marrow stromal cells. Oncogene (1991) 0.82
Analysis of the individual contributions of immunoglobulin heavy and light chains to the binding of antigen using cell transfection and plasmon resonance analysis. J Immunol Methods (1996) 0.81
An efficient immunization protocol for production of monoclonal antibodies against soluble human insulin. Immunol Lett (1994) 0.81
Efficient amplification and direct sequencing of mouse variable regions from any immunoglobulin gene family. FEBS Lett (1999) 0.81
Genetically engineered antibodies in gene transfer and gene therapy. Hum Gene Ther (1998) 0.80
Sustained systemic delivery of monoclonal antibodies by genetically modified skin fibroblasts. J Invest Dermatol (2000) 0.79
Cellular and viral Fos proteins are degraded by different proteolytic systems. Oncogene (2001) 0.79
Systemic long-term delivery of antibodies in immunocompetent animals using cellulose sulphate capsules containing antibody-producing cells. Gene Ther (1998) 0.79
Antiviral activity of an intracellularly expressed single-chain antibody fragment directed against the murine leukemia virus capsid protein. Hum Gene Ther (2000) 0.78
The muridae glyceraldehyde-3-phosphate dehydrogenase family. J Mol Evol (1989) 0.78
Cloning and expression of a single-chain antibody fragment specific for a monomorphic determinant of class I molecules of the human major histocompatibility complex. Hybridoma (1995) 0.78